1230 VivoVec lentiviral vector particles surface-engineered with T cell activating and co-stimulatory ligands enhance<i>in vivo</i>CAR T cell generation and antitumor activity
Chris Nicolai, Wai‐Hang Leung(Biogen (United States)), Way Wu, Ryan Larson(CTI BioPharma (United States)), Mollie M. McDonnell(University of Washington), Max Chen, Byoung Y. Ryu(CTI BioPharma (United States)), Laurie Beitz(Seattle Children's Hospital), Greyson Hamilton, Andrew M. Scharenberg(CTI BioPharma (Italy)), Shon Green, Erica Shirazi, Kathryn Michels(CTI BioPharma (United States)), Susana Hernández, Don Parrilla(CTI BioPharma (United States)), Jim Qin(Centenary Institute)
Cited by 0
Related Papers
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
|New England Journal of Medicine|2006|902
ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology
|Nature|2001|897